Clinical Trials Sponsored by Erimos Pharmaceuticals

Total 19899 results

Erimos Pharmaceuticals

Terminated

A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors

Lymphoma | Refractory Solid Tumors

United States
Erimos Pharmaceuticals

Terminated

Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Chronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Acute Lymphocytic Leukemia (ALL) | Leukemias | Adult T Cell Leukemia (ATL) | Chronic Myeloid Leukemia (CML-BP)

United States
Erimos Pharmaceuticals

Completed

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors

Cancer

United States
Primus Pharmaceuticals

Withdrawn

Safety and Efficacy of Vasculera® in the Healing of Diabetic Skin Ulcers

Diabetic Ulcers

United States
Primus Pharmaceuticals

Completed

Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon

Raynaud's Disease

United States
Primus Pharmaceuticals

Completed

Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee

Osteoarthritis

United States
Primus Pharmaceuticals

Completed

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

Osteoarthritis

United States
Primus Pharmaceuticals

Completed

Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee

Osteoarthritis of Knee
Cerimon Pharmaceuticals

Terminated

Basiliximab Maintenance in Ulcerative Colitis

Ulcerative Colitis

United Kingdom
Primus Pharmaceuticals

Terminated

EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment

Irritant Contact Dermatitis

United States
Primus Pharmaceuticals

Completed

Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee

Osteoarthritis

United States
Primus Pharmaceuticals

Completed

Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study.

Hyperlipidemia
Cerimon Pharmaceuticals

Completed

Basiliximab in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Poland, Belgium, United Kingdom, Czech Republic, Russian Federation, Slovakia, Ukraine, India
Cerimon Pharmaceuticals
PPD

Terminated

Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain

Ankle Sprain

United States
Cerimon Pharmaceuticals
PPD

Completed

Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis

Rotator Cuff Tendonitis | Bicipital Tendonitis | Subdeltoid Bursitis of the Shoulder | Subacromial Bursitis of the Shoulder | Medial Epicondylitis of the Elbow | Lateral Epicondylitis of the Elbow | DeQuervain's Tenosynovitis of the Wrist

United States
Cerimon Pharmaceuticals
PPD

Terminated

The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis (BSX-003)

Non-infectious Uveitis

United States
Cerimon Pharmaceuticals
PPD

Completed

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)

Acute Pain | Soft Tissue Injury

United States
Cerimon Pharmaceuticals
PPD

Completed

Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion (WIND)

Acute Pain

United States
Cerimon Pharmaceuticals
PPD

Completed

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain (SUPPORT 2)

Acute Pain | Ankle Sprain

United States
Primus Pharmaceuticals
Illumination Health

Recruiting

Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.

Lumbar Spinal Stenosis | Sciatica Acute

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

Psoriasis

United States
Primus Pharmaceuticals
Prosoft Clinical

Terminated

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis (BDS1307)

Plaque Psoriasis

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

Psoriasis

United States
Primus Pharmaceuticals
Northeastern University

Completed

Collected Data of Medical Food, Vasculera or Diosmiplex, in Clinic Patients 20 to 70 Years Old Diagnosed With Lipedema

Lipedema

United States
Primus Pharmaceuticals
Prosoft Clinical

Terminated

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Psoriasis

United States
Erimos Pharmaceuticals
Medical University of South Carolina; Duke University

Completed

Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck

Head and Neck Neoplasms

United States
Primus Pharmaceuticals
KGK Science Inc.

Not yet recruiting

Study of Diosmin-Diosmetin for the Treatment of Digital Ulcers in Systemic Sclerosis

Scleroderma, Systemic | Digital Ulcer
University of Messina
Primus Pharmaceuticals

Completed

Third Year Evaluation on Genistein Efficacy and Safety

Menopause | Osteopenia
Spectrum Health Hospitals
Primus Pharmaceuticals

Withdrawn

Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting

Varicose Veins | Venous Insufficiency of Leg | Venous Reflux | Lower Extremity Edema Chronic

United States
Primus Pharmaceuticals
Sun Valley Arthritis Center

Recruiting

Effect of Metaxalone 640 mg (M640) on Truck Driving Ability and Cognition Compared to Other Skeletal Muscle Relaxants

Cognitive Impairment

United States
Primus Pharmaceuticals
ClinOhio Research Services, LLC

Recruiting

Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg

Healthy Participants

United States
Erimos Pharmaceuticals
University of Maryland, Baltimore County; Planned Parenthood Delaware (Wilmington...

Completed

A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

United States
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); Erimos Pharmaceuticals

Completed

Terameprocol in Treating Patients With Recurrent High Grade Glioma

High Grade Glioma (III or IV)

United States
Alexion Pharmaceuticals, Inc.
Eidos Therapeutics, a BridgeBio company

Active, not recruiting

A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM

Symptomatic Transthyretin Amyloid Cardiomyopathy

Japan
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA2)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee (FACT CLBP 1)

Osteoarthritis | Chronic Low Back Pain

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Type 2 Diabetes

United States
Tibotec Pharmaceuticals, Ireland
Tibotec Pharmaceutical Limited

Completed

A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children

Human Immunodeficiency Virus 1

South Africa, Argentina, Brazil, India, Kenya
Vertex Pharmaceuticals Incorporated
Tibotec Pharmaceutical Limited

Completed

A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

Hepatitis C

United States
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Poland, United Kingdom
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States

Clinical Trials Sponsored by Erimos Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations